← Back to Search

Characterization of learning for Aphasia

N/A
Waitlist Available
Led By Sofia Vallila-Rohter, PhD
Research Sponsored by MGH Institute of Health Professions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights

Study Summary

This trialwill explore how brain damage and language abilities affect a person's ability to learn, impacting their aphasia treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Observational learning ability
Rule-based learning ability
Secondary outcome measures
Cognitive score
Language severity
Percent spared tissue

Trial Design

1Treatment groups
Experimental Treatment
Group I: Characterization of learningExperimental Treatment2 Interventions
All participants are assigned to complete behavioral (computer-based) learning tasks that measure their ability to learn observationally (observational learning ability) and via rules (rule-based learning ability).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Observational Learning
2020
N/A
~20
Rule-based Learning
2020
N/A
~20

Find a Location

Who is running the clinical trial?

National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
327 Previous Clinical Trials
178,197 Total Patients Enrolled
36 Trials studying Aphasia
2,681 Patients Enrolled for Aphasia
MGH Institute of Health ProfessionsLead Sponsor
15 Previous Clinical Trials
3,637 Total Patients Enrolled
2 Trials studying Aphasia
110 Patients Enrolled for Aphasia
Sofia Vallila-Rohter, PhDPrincipal InvestigatorMGH Institute of Health Professions

Media Library

Observational Learning Clinical Trial Eligibility Overview. Trial Name: NCT05119023 — N/A
Aphasia Research Study Groups: Characterization of learning
Aphasia Clinical Trial 2023: Observational Learning Highlights & Side Effects. Trial Name: NCT05119023 — N/A
Observational Learning 2023 Treatment Timeline for Medical Study. Trial Name: NCT05119023 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To whom does this clinical research opportunity extend?

"This study is currently seeking 55 individuals suffering from aphasia, whose age ranges between 18 to 80. Most importantly, they must meet the following requirements: post-stroke left hemisphere aphasia in its chronic stages (at least 6 months after onset), normal vision with or without corrective lenses, medical and neurological stability, and mobility of at least wheelchair status."

Answered by AI

Does this research project permit applicants who are below 30 years of age?

"This clinical trial's guidelines stipulate that patients must be aged between 18 and 80 to join. There are 5 trials specifically designed for minors, while 86 have been created with elderly individuals in mind."

Answered by AI

Is there a recruitment process currently open for this research project?

"Clinicaltrials.gov reveals that this particular medical study is no longer recruiting subjects; it was first posted on December 1st 2020 and the listing was last updated October 26th 2022. However, there are 86 other trials actively looking for participants currently available."

Answered by AI
~4 spots leftby Apr 2025